Xencor Inc

XNCR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001326732

SEC filings (opens in a new tab)

In the last 90 days, Xencor Inc insiders filed 0 open-market purchases and 2 sales; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 12, 2026: $2.86B
Insider buysOpen market, last 90 days: 0
Insider sellsLast 90 days, $3.59M in total: 2
13F holdersQ2 2026, +8 vs. previous quarter: 208
13F valueReported value at the end of Q2 2026: $1.36B
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $125.6M; +13.7% year over year
Net income, FY2025: -$91.9M; No comparable prior period
Free cash flow, FY2025: -$138.3M; No comparable prior period
Revenue, Q3 FY2026: $116.5M; +454.9% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $91.9M (73.2% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 12.9M; Shares sold short
Change: +629.9K; +5.1% vs. previous
Days to cover: 6.58; At average daily volume

Superinvestors holding XNCR, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding XNCR at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Xencor Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 12, 2026 (view filing)6:14 PM ET	Nov 11	1 day	Cornelissen Bart JanSR. VICE PRESIDENT & CFO	SSale	−10.1K	$39.82	−$402.2K	−13.3%65.8K after
Nov 12, 2026 (view filing)6:14 PM ET	Nov 10	2 days	Ranieri Richard JDirector	SSale	−81.3K	$39.25	−$3.19M	−81.4%18.5K after	2 lots
Jun 22, 2026 (view filing)	Jun 18	4 days	Feigal EllenDirector	SSale	−6.84K	$13.06	−$89.4K	−35.7%12.3K after	10b5-1
Jun 17, 2026 (view filing)	Jun 15	2 days	Gustafson Kurt ADirector	SSale	−5.47K	$12.31	−$67.4K	−27.1%14.7K after	10b5-1
Jun 17, 2026 (view filing)	Jun 15	2 days	Montgomery Alan BruceDirector	SSale	−5.06K	$12.31	−$62.3K	−24.6%15.5K after	10b5-1
Jun 17, 2026 (view filing)	Jun 15	2 days	Ranieri Richard JDirector	SSale	−5.47K	$12.31	−$67.4K	−28.5%13.7K after	10b5-1
Jun 17, 2026 (view filing)	Jun 15	2 days	Gorman Kevin CharlesDirector	SSale	−7.53K	$12.31	−$92.7K	−39.8%11.4K after	10b5-1
Apr 13, 2026 (view filing)	Apr 10	3 days	Cornelissen Bart JanSR. VICE PRESIDENT & CFO	SSale	−3.50K	$12.29	−$43.0K	−4.4%75.9K after
Mar 9, 2026 (view filing)	Mar 5	4 days	Cornelissen Bart JanSR. VICE PRESIDENT & CFO	SSale	−2.52K	$11.25	−$28.3K	−3.1%79.4K after
Mar 9, 2026 (view filing)	Mar 5-6	4 days	Eckert CeliaSVP, GENERAL COUNSEL	SSale	−5.01K	$11.17	−$56.0K	−6.1%76.9K after	2 lots

Top 10 13F holders, Q2 2026

See all 208 holders

The largest institutional positions in Xencor Inc at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding XNCR in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
BlackRock, Inc.	13,651,261	$219.8M	0.00%	+615,343+4.7%	Added
Primecap Management Co	10,181,322	$163.9M	0.10%	−156,700−1.5%	Reduced
BVF Inc	7,133,720	$114.9M	2.94%	00.0%	Unchanged
RTW Investments, LP	6,777,461	$109.1M	0.93%	00.0%	Unchanged
Ra Capital Management, L.P.	5,274,274	$84.9M	0.74%	+377,037+7.7%	Added
State Street Corp	4,954,016	$79.8M	0.00%	+601,980+13.8%	Added
Vanguard Capital Management LLC	3,278,802	$52.8M	0.00%	+177,155+5.7%	Added
TCG Crossover Management, LLC	2,452,138	$39.5M	0.95%	00.0%	Unchanged
Price T Rowe Associates Inc	2,356,409	$37.9M	0.00%	+795,989+51.0%	Added
Vanguard Portfolio Management LLC	2,215,690	$35.7M	0.00%	−1,284,652−36.7%	Reduced

Holders of 5% or more of XNCR

See all 6 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Xencor Inc.

Largest holders of XNCR from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
BlackRock, Inc.	13G/A	14.50%10.8M shares	−1.30 ppfrom 15.80%	Oct 18, 20245 filings	Oct 27, 2026	SEC
Primecap Management Co	13G/A	13.29%9.88M shares	−1.50 ppfrom 14.79%	Feb 12, 20218 filings	Nov 6, 2026	SEC
Biotechnology Value Fund L P	13G/A	9.99%7.13M shares	+3.49 ppfrom 6.50%	Oct 17, 20252 filings	Feb 17, 2026	SEC
RTW Investments, LP	13G	8.70%6.22M shares	New	Nov 14, 20251 filing	Nov 14, 2025	SEC
Ra Capital Management, L.P.	13G	6.50%4.74M shares	New	Mar 30, 20261 filing	Mar 30, 2026	SEC